Mr David Jay Goodkind, MD | |
2 Chestnut Street, Branford, CT 06405 | |
(203) 871-3799 | |
(203) 646-9719 |
Full Name | Mr David Jay Goodkind |
---|---|
Gender | Male |
Speciality | Surgery - Plastic And Reconstructive Surgery |
Location | 2 Chestnut Street, Branford, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821031899 | NPI | - | NPPES |
001241793 | Medicaid | CT | |
1241793 | Medicaid | CT |
Mailing Address | Practice Location Address |
---|---|
Mr David Jay Goodkind, MD 2 Chestnut Street, Branford, CT 06405 Ph: (203) 871-3799 | Mr David Jay Goodkind, MD 2 Chestnut Street, Branford, CT 06405 Ph: (203) 871-3799 |
News Archive
The School Nutrition Association now says the new rules are too costly. Meanwhile, NPR looks at the difficulties for employers to deal with workers' weight problems and the increasing number of obese seniors.
Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director Abramson Cancer Center, study body clock proteins associated with cancer cells.
DJO Global, Inc. today announced that Megan Rapinoe, Olympic gold medalist for the U.S. Women's Soccer Team and member of the Seattle Reign FC, a part of the National Women's Soccer League, is partnering with the medical device company to help educate young athletes on the value of bracing in both injury prevention and returning to play.
Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.
A clinical research study is being conducted for patients with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS), a chronic bladder disorder characterized by intense pelvic pain, urinary frequency-urgency, and pain during sexual intimacy (www.PainfulBladderStudy.org). It is estimated that as many as 1.3 million people in the U.S. have been diagnosed with this disease and many more remain undiagnosed.
› Verified 5 days ago
Raymond Joseph Ippolito, MD Surgery Medicare: Medicare Enrolled Practice Location: 420 East Main Street, Bldg 2 Unit 5, Branford, CT 06405 Phone: 203-481-6722 Fax: 203-483-2074 |